Galmed Pharmaceuticals (GLMD) News Today $2.85 -0.11 (-3.72%) (As of 11:58 AM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Galmed Pharmaceuticals (NASDAQ:GLMD) Share Price Passes Below Two Hundred Day Moving Average - Should You Sell?November 14, 2024 | americanbankingnews.comGalmed Pharmaceuticals Amends Equity Purchase AgreementOctober 23, 2024 | markets.businessinsider.comGalmed publishes Results from Aramchol Phase 3 Open Label part in HepatologySeptember 25, 2024 | prnewswire.comMarketBeat Week in Review – 9/16 - 9/20 (GLMD)Stocks got a boost as the Federal Reserve cut interest rates, but investors should expect more volatility as economic data continues to deliver mixed signalsSeptember 21, 2024 | marketbeat.comBenzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About YetSeptember 20, 2024 | benzinga.comGalmed Pharmaceuticals Stock Is Soaring Thursday: Here's WhySeptember 19, 2024 | msn.comGalmed Announces an Expansion of its Activities to Cancer and major Cardiometabolic DiseasesSeptember 19, 2024 | prnewswire.comGalmed Pharmaceuticals (NASDAQ:GLMD) Stock, Short Interest ReportSeptember 19, 2024 | benzinga.comGalmed Pharmaceuticals Down 53%, But Still Well Above Monday Closing PriceSeptember 18, 2024 | marketwatch.comGalmed Pharmaceuticals Soars Nearly 500% Amid Nasdaq Compliance and Short SqueezeSeptember 18, 2024 | msn.comCrude Oil Gains Over 1%; US Business Inventories Increase In JulySeptember 18, 2024 | msn.comGalmed Pharmaceuticals Surges After Regaining Nasdaq ComplianceSeptember 17, 2024 | marketwatch.comGalmed Pharma Surges 400%: What's Behind the Explosion?September 17, 2024 | msn.comGalmed Pharmaceuticals Surges 400%: What's Behind the Explosion?Galmed Pharmaceuticals (NASDAQ: GLMD) stock skyrocketed nearly 400%, trading over 80 million shares, compared to its average of 75,000.September 17, 2024 | marketbeat.comGalmed Pharmaceuticals Ltd.August 25, 2024 | barrons.comGLMD Stock Earnings: Galmed Pharmaceuticals Reported Results for Q1 2024June 22, 2024 | investorplace.comGalmed Pharmaceuticals (NASDAQ: GLMD)April 13, 2024 | fool.comWall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024April 10, 2024 | investorplace.comGalmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2023April 4, 2024 | prnewswire.comGalmed Granted European Patent For Use Of Aramchol-Resmetirom To Treat NASH/MASH, Liver FibrosisMarch 15, 2024 | markets.businessinsider.comGalmed Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of NASH and Liver FibrosisMarch 15, 2024 | prnewswire.comGalmed Pharmaceuticals Ltd (GPH.BE)February 13, 2024 | uk.finance.yahoo.comGalmed Pharmaceuticals Ltd. (GPH.F)January 3, 2024 | uk.finance.yahoo.comGalmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a StudyNovember 20, 2023 | finance.yahoo.comGalmed Pharmaceuticals Ltd GLMDNovember 4, 2023 | morningstar.comGalmed Announces Allowance of New Patent for Aramchol for the Treatment of Pulmonary and Dermal FibrosisSeptember 26, 2023 | finance.yahoo.comGalmed Pharmaceuticals (GLMD) Price Target Increased by 300.00% to 4.08August 3, 2023 | nasdaq.comGalmed Pharma Shares Drop 30% After Public Offering PricesJuly 14, 2023 | marketwatch.comGalmed shares slump on pricing discounted stock and warrants offeringJuly 14, 2023 | seekingalpha.comGalmed Pharmaceuticals Announces Pricing of $7 Million Public OfferingJuly 14, 2023 | finance.yahoo.comTrading was temporarily halted for "GLMD" at 09:07 AM with a stated reason of "LULD pause."July 14, 2023 | marketbeat.comWhy Is Galmed Pharmaceuticals (GLMD) Stock Moving Today?July 13, 2023 | investorplace.comTrading was temporarily halted for "GLMD" at 12:07 PM with a stated reason of "LULD pause." Trading set to resume at 12:07 PM. July 12, 2023 | marketbeat.comTrading was temporarily halted for "GLMD" at 12:07 PM with a stated reason of "LULD pause."July 12, 2023 | marketbeat.comTrading was temporarily halted for "GLMD" at 12:07 PM with a stated reason of "LULD pause."July 12, 2023 | marketbeat.comGalmed to employ OnKai's disruptive Artificial Intelligence (AI) in its Planned Phase 2a Clinical Trial in PSCJuly 10, 2023 | finance.yahoo.comMadrigal begins process seeking OK for multibillion-dollar — yet elusive — NASH drugJuly 3, 2023 | bizjournals.comGalmed Pharmaceuticals Stock (NASDAQ:GLMD), Insider Trading ActivityJune 3, 2023 | benzinga.comGalmed Pharmaceuticals Ltd.: Galmed Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent DevelopmentsJune 1, 2023 | finanznachrichten.deRecap: Galmed Pharmaceuticals Q1 EarningsJune 1, 2023 | msn.comGalmed Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent DevelopmentsJune 1, 2023 | finance.yahoo.comWhy Galmed Pharmaceuticals (GLMD) Stock Is Surging TodayMay 17, 2023 | thestreet.comAnalysts Offer Insights on Healthcare Companies: Galmed Pharmaceuticals (GLMD) and Haemonetics (HAE)May 11, 2023 | markets.businessinsider.comGalmed Announces Initiation of a Clinical Development Program to Evaluate Aramchol meglumine for the Treatment of Primary Sclerosing Cholangitis (PSC)May 9, 2023 | finance.yahoo.comWhy Is Galmed Pharmaceuticals (GLMD) Stock Up 37% Today?May 5, 2023 | msn.comGalmed Pharmaceuticals forms a Strategic Partnership with OnKaiMay 4, 2023 | finance.yahoo.comGalmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2022March 29, 2023 | finance.yahoo.comGLMD Galmed Pharmaceuticals Ltd.February 17, 2023 | seekingalpha.comGalmed Announces Issuance of New Composition of Matter Patent for Aramchol meglumine SaltFebruary 8, 2023 | finance.yahoo.comCan Galmed Pharmaceuticals (NASDAQ:GLMD) Afford To Invest In Growth?January 6, 2023 | finance.yahoo.com Get Galmed Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for GLMD and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin GLMD Media Mentions By Week GLMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GLMD News Sentiment▼0.750.47▲Average Medical News Sentiment GLMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GLMD Articles This Week▼00▲GLMD Articles Average Week Get Galmed Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for GLMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies APM News Today BCLI News Today CANF News Today BIOR News Today ABVC News Today EVOK News Today EDSA News Today GTBP News Today EYEN News Today ADIL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GLMD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galmed Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galmed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
